Peptides DB
Research-centric peptide and protocol reference hub
Study 1 of 10Triptorelin literaturebiorxiv-preprint · Observational2026

Pubertal Triptorelin Exposure Alters Hypothalamic Reproductive–Metabolic Integration in a Sex-Specific Manner

Triptorelin treatment during puberty leads to reproductive suppression and distinct metabolic changes in male and female rats, indicating broader neuroendocrine effects beyond reproductive maturation.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the triptorelin corpus
0
Preclinical
8
Observational · this one
0
Open-label
1
Randomised
1
Reviews

Summary and findings

This study examined the effects of triptorelin on reproductive and metabolic integration in male and female Wistar rats. The rats received a depot triptorelin injection at pubertal onset, and various physiological parameters were monitored over 28 days. Results indicated significant reproductive suppression and sex-specific metabolic responses.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as biorxiv-preprint supplied them

Gonadotropin-releasing hormone agonists are used to treat central precocious puberty and are increasingly prescribed in gender-affirming care. Despite well-established reproductive effects, their broader physiological effects during puberty remain poorly understood. Male and female Wistar rats received a depot triptorelin injection at pubertal onset. Body mass, food intake, and locomotor activity were monitored. After 28 days, reproductive function was assessed, and pituitary and hypothalamic gene expression was analyzed. Changes in gonadal weight, estrous cycle, folliculogenesis, seminiferous tubules’ morphology, and sperm count confirmed the suppression of pubertal maturation. Triptorelin downregulated Gnrhr and Lhb, demonstrating suppression of gonadotrope function. Despite comparable reproductive suppression, metabolic responses to triptorelin were strongly sex-dependent. Females exhibited increased body weight gain accompanied by delayed hyperphagia, whereas males showed reduced body weight gain, unchanged food intake, and increased mean locomotor speed. Female-specific transcriptional remodeling was observed in the hypothalamus, characterized by downregulation of Lepr and Npy and upregulation of Sst and Kiss1 expression. Collectively, these findings demonstrate that pubertal triptorelin treatment induces profound reproductive suppression in both sexes while eliciting sex-specific hypothalamic adaptations in pathways regulating energy homeostasis. This suggests that puberty blockers exert broader neuroendocrine effects beyond the suppression of reproductive maturation.

Elsewhere in the Triptorelin corpus

AComparative effectiveness of luteal phase support strategies in natural cycle frozen-thawed embryo transfer: a systematic review and network meta-analysis.European journal of obstetrics, gynecology, and reproductive biology · 2026 · Not reported in abstract.reviewCProposed Method for Mass Spectrometric Measurement of the Gonadotropin-Releasing Hormone Agonist Deslorelin.Toxics · 2026 · Detectability optimized to <1 ppb.AnimalBComparison of cardiovascular events in patients with metastatic hormone sensitive prostate cancer treated with LHRH agonists to LHRH antagonists in the US: A retrospective cohort study.Urologic oncology · 2026 · n=6666 · HR for MACE with LHRH-AG vs LHRH-AN was 0.86, 95% CI: 0.79-0.93.HumanAEvaluation of triplet therapy combined with robot-assisted cytoreductive prostatectomy for high-volume metastatic prostate cancer: a multicentre randomised controlled trial protocol.BJU international · 2026 · n=88 · Not reported in abstract.HumanBOptimizing ovarian stimulation in oocyte donation: exploratory comparison of rhFSH (2:1) versus hp-hMG under PPOS protocols.JBRA assisted reproduction · 2023 · n=36 · Mean number of good-morphology blastocysts per cycle was 4.5 with rhFSH:rhLH vs 2.0 with hp-hMG.HumanBTreatment Outcomes in 84 Male Children with Accelerated Pubertal Progression: A Comparative Analysis ofGnRHa, Combined GH Therapy and Aromatase Inhibitorbiorxiv-preprint · 2026 · ΔH/y of combination therapy was 8.49 ± 3.22 cm/y, GnRHa was 6.73 ± 1.95 cm/y, and AI was 7.75 ± 1.92 cm/y, P < 0.01.Human